Pharma
Regulatory
Takeda’s Vyvanse (lisexamfetamine dimesylate) Chewable Tablet Receives Health Canada’s Approval
Shots: The approval is based on the clinical study results assessing the bioavailability of chewable Vyvanse tablets vs Vyvanse capsule formulation post 60mg (qd) administration under fasting condition in 18 […]readmore